TRPC3 is frequently overexpressed in triple-negative breast cancer (TNBC), where it drives proliferation and chemoresistance via the TRPC3–RASA4–MAPK (TRP3-Ras GTPase-activating protein 4-MAPK) axis. Here, TRPC3 is linked to triple-negative breast carcinoma.